when NASA’s SpaceX Crew-9 launched to the International Space Station (ISS) on September 28th. One of the studies sponsored by the ISS National Laboratory included a student-led project aimed at investigating the effects of radiation and the space environment on gene editing mechanisms.
The ISS National Laboratory said in a statement that data from the project, led by principal investigator Isabelle Jean, could help better protect astronauts and uncover genetic risks for some diseases during space travel. He said that this could be useful in developing technology to
Four National Science Foundation (NSF)-funded studies will be conducted during the impending Commercial Supply Services mission, including Oregon State University and Texas Tech University, targeting heart health. Also includes joint projects.
The experiment “uses 3D bioprinted cardiac organoids to study cardiomyocyte atrophy induced by microgravity,” the ISS National Laboratory said in a statement.
According to the NIH’s National Library of Medicine, Cardiac organoids are in vitro self-assembled three-dimensional structures composed of multiple cardiac cells, including cardiomyocytes, endothelial cells, and cardiac fibroblasts, with or without a biological scaffold.
Researchers hope that the data from this study may improve our understanding of myocardial atrophy, which can be present in cancer, muscle diseases, muscular dystrophy, diabetic sepsis, heart failure, and more.
Additionally, several NASA-funded and ISS-sponsored projects will be the focus. Research into manufacturing in space, including research by Sachi Bioworks in partnership with Space Tango. The study will use brain organoids in microgravity to test the effectiveness of new drugs against three neurodegenerative diseases: Alzheimer’s disease, Parkinson’s disease, and dementia.
The researchers plan to study the results to see if they can facilitate the expansion of new treatments. For patients around the world.
bigger trends
In August, ISS National Institute and NASA will provide up to $4 million, divided into two to three awards, for projects that leverage the space environment and technology to develop treatments for diseases on Earth. Published research presentation (NLRA).
In 2023, NASA has sent four astronauts to the ISS on a six-month scientific expedition to conduct research to improve medical options on Earth.
In 2022, Four astronauts went to the ISS as part of SpaceX’s Fifth Commercial Crew Mission to conduct multiple research studies sponsored by the ISS National Laboratory.
